HEMOLYTIC ANEMIA

Authors

  • Akhmedov Bakhtiyor Khabibulaevich Departments of Hospital Therapy and Endocrinology, Andijan State Medical Institute

Keywords:

Anemia, diseases, treatments, WHO, MCV, Hemolytic anemia, purple blood

Abstract

Hemolytic anemia is a type of anemia characterized by the premature destruction of red blood cells, leading to a reduction in the number of red blood cells in the circulation. This condition can be caused by a variety of factors, including genetic mutations, autoimmune disorders, and infections. In this article, we will provide a comprehensive review of the pathophysiology, clinical presentation, and treatment options for hemolytic anemia.

Downloads

Download data is not yet available.

References

Ataga KI, Gordeuk VR, Agodoa I, Colby JA, Gittings K, Allen IE. Low hemoglobin increases risk for cerebrovascular disease, kidney disease, pulmonary vasculopathy, and mortality in sickle cell disease: A systematic literature review and meta-analysis. PLoS One. 2020;15(4): e0229959.

Jäger U, Barcellini W, Broome CM, Gertz MA, Hill A, Hill QA, Jilma B, Kuter DJ, Michel M, Montillo M, Röth A, Zeerleder SS, Berentsen S. Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting. Blood Rev. 2020 May; 41:100648.

Qian Q, Nath KA, Wu Y, Daoud TM, Sethi S. Hemolysis and acute kidney failure. Am J Kidney Dis. 2010 Oct;56(4):780-4.

Frank JE. Diagnosis and management of G6PD deficiency. Am Fam Physician. 2005 Oct 01;72(7):1277-82.

Walshe JM. The acute haemolytic syndrome in Wilson's disease--a review of 22 patients. QJM. 2013 Nov;106(11):1003-8.

Published

2024-10-27

How to Cite

Akhmedov Bakhtiyor Khabibulaevich. (2024). HEMOLYTIC ANEMIA. Journal of Applied Science and Social Science, 14(10), 151–154. Retrieved from https://www.internationaljournal.co.in/index.php/jasass/article/view/332